Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FK38C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,070
Award facts
- Contract value 100% obligated
- $12,070.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,070.09 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units). This firm fixed price, non-set-aside contract was awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award is issued under a larger contract vehicle—specifically the company's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Gemtesa—a medication used in the treatment of overactive bladder—represents a routine fulfillment within the company's broad pharmaceutical support mission for the Defense Health Agency and other federal healthcare customers. The competitive, non-set-aside award reflects AmerisourceBergen's established capacity to meet federal procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FK38C?
SPE2DB25FK38C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FK38C worth?
The government has obligated $12,070 on SPE2DB25FK38C.
Is contract SPE2DB25FK38C an order under another contract?
Yes. SPE2DB25FK38C is a delivery order under SPE2DB20D1110, an indefinite delivery contract.
Was contract SPE2DB25FK38C competed?
The extent of competition for SPE2DB25FK38C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award